School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
Bioorg Med Chem Lett. 2013 Jan 1;23(1):297-300. doi: 10.1016/j.bmcl.2012.10.097. Epub 2012 Nov 1.
Protein tyrosine phosphatase 1B (PTP1B) is an important factor in non-insulin-dependent diabetes mellitus (type-2 diabetes), and a promising target for treatment of diabetes and obesity. Therefore, the aim of this study is to investigate the inhibitory activities of constituents (three new together with twelve known triterpenes compounds) isolated from the hydrolyzate of total saponins from Gynostemma pentaphyllum. Their structures were accomplished mainly base on the spectroscopic methods, and then were further confirmed by X-ray crystal diffraction. All the compounds were evaluated for inhibitory activity against PTP1B. Current data suggested that the compounds 1, 3, 12, 13 and 14 were considered to be potential as antidiabetic agents, in which they could significantly inhibit the PTP1B enzyme activity in a dose-dependent manner.
蛋白酪氨酸磷酸酶 1B(PTP1B)是 2 型糖尿病(非胰岛素依赖型糖尿病)的一个重要因素,也是治疗糖尿病和肥胖的一个有前途的靶点。因此,本研究旨在研究从绞股蓝总皂苷水解产物中分离得到的成分(三种新的和十二种已知的三萜类化合物)的抑制活性。它们的结构主要是基于光谱方法确定的,然后通过 X 射线晶体衍射进一步证实。所有化合物均针对 PTP1B 的抑制活性进行了评估。目前的数据表明,化合物 1、3、12、13 和 14 被认为是有潜力的抗糖尿病药物,它们可以显著地抑制 PTP1B 酶的活性,且呈剂量依赖性。